Central nervous system (CNS) risks which include during space missions and lifetime risks due to space radiation exposure are of concern for long-term exploration missions to Mars or other destinations. Possible CNS risks during a mission are altered cognitive function, including detriments in short-term memory, reduced motor function, and behavioral changes, which may affect performance and human health. The late CNS risks are possible neurological disorders such as premature aging, and Alzheimer's disease (AD) or other dementia. Radiation safety requirements are intended to prevent all clinically significant acute risks. However the definition of clinically significant CNS risks and their dependences on dose, dose-rate and radiation quality is poorly understood at this time. For late CNS effects such as increased risk of AD, the occurrence of the disease is fatal with mean time from diagnosis of early stage AD to death about 8 years. Therefore if AD risk or other late CNS risks from space radiation occur at mission relevant doses, they would naturally be included in the overall acceptable risk of exposure induced death (REID) probability for space missions. Important progress has been made in understanding CNS risks due to space radiation exposure, however in general the doses used in experimental studies have been much higher than the annual galactic cosmic ray (GCR) dose (∼0.1 Gy/y at solar maximum and ∼0.2 Gy/y at solar minimum with less than 50% from HZE particles). In this report we summarize recent space radiobiology studies of CNS effects from particle accelerators simulating space radiation using experimental models, and make a critical assessment of their relevance relative to doses and doserates to be incurred on a Mars mission. Prospects for understanding dose, dose-rate and radiation quality dependencies of CNS effects and extrapolation to human risk assessments are described.
Introduction
Experimental studies at particle accelerators with protons and high charge and energy (HZE) nuclei have suggested that during mission and late risks to the central nervous system (CNS) from galactic cosmic rays (GCR) and solar particle events (SPEs) could be a limitation to human exploration of our solar system (NAS, 1973 (NAS, , 1996 NCRP, 2006; Cucinotta et al., 2009 ). However, there remains an important scientific challenge of extrapolating observations from these studies to humans and vital need to perform new experiments at space relevant doses and dose-rates to understand the during mission and late CNS risks. Because of the relatively low doses of space missions (<0.5 Gy), the early (during mission) space radiation CNS risks will likely be distinct compared to acute and delayed radiation injury that occur after very high doses of * Correspondence to: University of Nevada, Las Vegas, Department of Health Physics and Diagnostic Sciences, 4505 S. Maryland Parkway, Box 453037, Las Vegas, NV 89154-3037, USA.
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radiation (Tofilon and Fike, 2000) . In addition, for during mission CNS risks there are potentially synergistic interactions with other spaceflight factors such as altered circadian rhythm and microgravity. In this review, we first summarize exposures to be encountered on Mars missions which show the maximum annual exposure from GCR to be no more than 0.2 Gy/y with less than 50% from HZE particles. Existing human data on CNS risks at low to moderate doses (<2 Gy) are briefly summarized. Recent studies in CNS radiobiology are then discussed, and recommendations on how to define new exposure conditions for CNS research to ensure their relevance for space conditions are discussed. Radiation protection both on Earth and in space (NCRP, 1989 ) is based on principles of risk justification and limitation. For stochastic effects such as cancer, acceptable risks are set with an upper limit of 1 in 33 probability of cancer mortality from occupational exposures (NCRP, 1989 (NCRP, , 2000 using the quantity risk of exposure induced death (REID) (Cucinotta et al., 2013a (Cucinotta et al., , 2013b Cucinotta, 2014) . This compares with the current estimate of 1 in 270 for loss of crew due to flight failures, while new technology investments expected to reduce this value to 1 in 750 (ASAP, 2010) . Dose limits for deterministic effects including risks to the skin, blood forming system, and lens are based on avoiding all risk with limits set at estimated doses below a likely threshold for clinically significant effects. Deterministic effects are expected to occur only above a dose threshold after a significant number of cells are damaged within a tissue, and with a severity that increases with dose, including an inverse correlation between dose and latency. The Casarett model of late tissue effects (Rubin and Casarett, 1968; Cox et al., 1983) suggests that significant effects will occur at lower doses, but with increased latency compared to higher doses. Recent debate has considered if cataracts will occur without a dose threshold (ICRP, 2012) . The increased incidence of cataracts observed after the low space radiation doses of past space missions (Cucinotta et al., 2001 , Chylack et al., 2009 Chylack et al., 2012) , where only a small fraction of cells in a tissue are damaged, suggests that new paradigms for deterministic effects should be considered. More extensive considerations may be needed for cognitive changes in the CNS that may occur during flight, which likely involve distinct biological factors compared to other tissues related to changes to synapse plasticity and distinct modes of oxidative damage.
In the past, limiting the risks to the CNS of adults exposed to low to moderate doses of ionizing radiation has not been a concern for occupational radiation exposure. CNS injury that occurs after high doses of radiation used in radiotherapy, including early delayed effects such as demyelination and late delayed effects such as vascular damage and white matter necrosis, are not a concern for spaceflight (Tofilon and Fike, 2000; Hopewell, 1994) . However, the HZE particle component of space radiation presents distinct biophysical challenges to cells and tissues compared to terrestrial forms of radiation. Soon after the discovery of cosmic rays, the concern for CNS risks originated with the prediction of the light flash phenomenon from single HZE nuclei traversals of the retina (Tobias, 1952) , which was later confirmed by the Apollo astronauts. HZE nuclei are capable of producing a column of heavily damaged cells along their path through tissues, described as a microlesion (NAS, 1973; Todd, 1989) , possibly leading to negative impacts on CNS function. In the last decade new hypotheses for mechanisms of HZE damage to the CNS have been described related to the observation of cognitive changes, the impacts by HZE nuclei on neurogenesis, and pathological changes related to Alzheimer's disease and other late effects in experimental studies of the CNS.
Human epidemiology is used as a basis for risk estimation for cancer, acute radiation risks, and cataracts using dose-response models from low LET exposures in humans combined with quality factors or relative biological effectiveness (RBE) factors and doserate modifiers determined from experimental models. However, this approach is not viable for estimating CNS risks from space radiation because there is no human data from low LET radiation exposure to develop a quantitative scaling approach for space radiation, and it is likely that HZE particles produce qualitatively different biological damage compared to X-rays or gamma-rays. At doses above a few Gy, detrimental CNS changes occur in humans treated with radiation (such as photons and protons) for cancer. Here treatment doses of 50 Gy or more are typical, which is well above the exposures in space even if a large SPE were to occur. Thus, of the categories of space radiation risks, which includes cancer, CNS, degenerative tissue effects, and acute radiation syndromes, CNS risk assessment will rely most extensively on experimental data with animals for its evidence base, and for the development of risk projection models.
CNS exposures in space
Both GCR and SPEs are of concern for CNS risks. The GCR are composed of protons, helium nuclei, and high charge and energy (HZE) nuclei. GCR energies ranging from less than 10 MeV/u (Zeitlin et al., 2013) 0.481 ± 0.08 1.84 ± 0.33 RAD Mars surface 0.205 ± 0.05 0.70 ± 0.17 * NSCR-2012 model predictions (Cucinotta et al., 2013a; Kim et al., 2014) .
to above 10,000 MeV/u with median energies inside tissue of about 1500 MeV/u for HZE components and several hundred MeV for protons and helium nuclei. Secondary particles are produced through nuclear reaction in shielding and tissue, including neutrons, protons, helium nuclei, mesons and gamma-rays. The high energies of GCR lead to practical ranges to 100's of cm of any material, thus precluding radiation shielding as an important mitigation approach to GCR risks on the CNS. For SPEs, the possibility exists for an absorbed dose of over 1 Gy from a SPE if the crew is in a thinly shielded spacecraft or during a spacewalk Kim et al., 2009) with the likelihood of a SPEs higher near solar maximum and lowest near solar minimum. The energies of SPE (10's to 100's of MeV), however, do not preclude radiation shielding as a potential countermeasure. Nevertheless, the costs of shielding may be too high to protect against the largest events that have occurred historically (Kim et al., 2009) . GCR dose-rates are accurately predicted by the NASA Space Cancer Risk Model (NSCR-2012) (Cucinotta et al., 2013a (Cucinotta et al., , 2013b as shown in previous reports comparing to flight measurements Cucinotta et al., 2013a; Zeitlin et al., 2013; Kim et al., 2014) . Table 1 shows comparison to the recent measurements on the cruise from Earth to Mars, and Martian surface from the MSL-RAD detector (Zeitlin et al., 2013; Hassler et al., 2014) . A high level of agreement between measurements and NSCR-2012 is found. Fig. 1 (Panel A) shows the variation of the GCR doserate as predicted by the NSCR-2012 model (Cucinotta et al., 2013a (Cucinotta et al., , 2013b . In Fig. 1 (Panel B) the contributions to the annual absorbed dose versus the charge number of the particle for several locations within the human brain are shown for the GCR at solar minimum. It is clear that in interplanetary space annual GCR organ doses will vary from about 0.1 Gy to 0.2 Gy per year for solar maximum to solar minimum, respectively and the HZE contribution to the absorbed doses will be 0.1 Gy/y or less (Cucinotta and Durante, 2006; Cucinotta et al., 2013a Cucinotta et al., , 2013b . Round-trip times to Mars are approximately 1-year, however there are also exposures on the surface of Mars with about half the free space dose-rate Hassler et al., 2014) . These doses will have lower percent-contributions from HZE particles due to their absorption in the Martian atmosphere and an increased contribution from neutrons (Kim et al., 2014) . Unfortunately many reports from CNS space radiobiology confuse reported estimates of absorbed dose with dose equivalent, and use estimates of dose equivalent to determine lower dose ranges for experimental design. Because average quality factors for GCR are ∼4, such studies are often considering minimal doses well above the annual GCR doses from HZE particles, while not addressing dose-rate effects.
Effects in humans and non-human primates at low to moderate doses

CNS risks after cancer therapy with radiation
Evidence of the effects of terrestrial forms of ionizing radiation on the CNS has been documented from the patients of (Cucinotta et al., 2013a (Cucinotta et al., , 2013b radiotherapy, although the dose is higher than would be experienced in the space environment. CNS behavioral changes such as chronic fatigue and depression occur in patients undergoing irradiation for cancer therapy. Neurocognitive effects are observed at lower doses, especially in children (Schultheiss et al., 1995; BEIR-V, 1990) . A review on intelligence and the academic achievement of children after treatment for brain tumors indicates that radiation is related to a decline in intelligence and academic achievement, including low score of intelligence quotients (IQ), verbal, performance IQ, as well as in academic achievement in reading, spelling and mathematics, and attention functioning (Butler and Haser J, 2006) . Mental retardation was observed in the children of the atomic-bomb survivors in Japan exposed prenatally at moderate doses (<2 Gy) at 8-15 weeks post-conception, but not at earlier or later times since conception (BEIR-V, 1990) . Radiotherapy for treatment of several types of tumors with protons and other charged particle beams provides ancillary data for considering radiation effects for the CNS. As reviewed in NCRP Report No. 153 (NCRP, 2006) radiotherapy data exists for treatment of pituitary tumors (Kjellberg and Kliman, 1979; Linfoot, 1979) , hormone-responsive metastatic mammary carcinoma (Tobias, 1979 ), brain tumors (Castro et al., 1985; Suit et al., 1982) , and intracranial arteriovenous malformations and other cerebrovascular diseases (Fabrikant et al., , 1985 (Fabrikant et al., , 1984 Kjellberg et al., 1983; Levy et al., 1989; Steinberg et al., 1990) . In these studies, associations with neurological complications are found, such as impairments in cognitive function, language acquisition, visual spatial ability, memory and executive function, as well as changes in social behaviors. Similar effects did not appear in patients treated with chemotherapy. In all of these examples the patients were treated with extremely high doses that were below the threshold for necrosis (Goldberg et al., 1982; Keime-Guibert et al., 1998) .
Studies of CNS risks in atomic-bomb survivors and radiation workers
More recently studies of possible CNS injury in adults after low to moderate doses of radiation (up to 2 Gy) have been considered in the A-bomb survivors (Yamada et al., 2009 ) and cleanup workers at the Chernobyl accident (Bromet et al., 2011) . In a study of 2200 survivors by Yamada et al. (2009) no association between increased risk of dementia in survivors and radiation dose was found. But this study is limited by several factors including the small subset of less than 3% of the survivors in the Japanese life-time study, the restriction to a small observational window many years after the exposure, and the difficulties in classifying early stages of dementia. Studies of the Chernobyl liquidator's suggests psychological effects have occurred years after the accident (Bromet et al., 2011) . However these studies are confounded by the quality of the individual dosimetry, and the overall cultural stigma of the Chernobyl accident.
Limitations to studies in astronauts
The possible observation of CNS effects in astronauts participating in past NASA missions is highly unlikely. First, because the lengths of past missions are relatively short and the population size of astronauts is small. Secondly, in low Earth orbit (LEO) astronauts are partially protected by the Earth's magnetic field and the solid body of the Earth, which together reduce the GCR doserate by about 2/3 from its free space values. Furthermore, the GCR in LEO has lower LET components compared to the GCR to be encountered in transit to Mars or on the lunar surface because the Earth's magnetic field repels nuclei with energies below about 1000 MeV/u, which are of higher LET. For these reasons, the CNS risks are of a higher concern for long-duration lunar missions or for a Mars mission than for missions on the International Space Station (ISS).
One area where direct observations of space radiation effects on astronauts has been demonstrated is the light flashes that were observed by the astronauts during the early Apollo missions and dedicated experiments subsequently performed on later Apollo and Skylab missions (Pinsky et al., 1974) . More recently, studies of light flashes have been made on the Russian Mir space station and the International Space Station (ISS) (Sannita et al., 2004) . A 1973 report by the National Academy of Science discussed these effects in detail. This phenomenon, known as a phosphene, is the visual perception of flickering light. It is considered a subjective sensation of light since it can be caused by simply applying pressure on the eyeball (NCRP, 2006) . The traversal of a single highly charged particle through the occipital cortex or the retina was estimated to be able to cause a light flash. Possible mechanisms for HZEinduced light flashes include direct ionization and Cerenkov radiation within the retina. The observation of light flashes by the Table 2 Limitations of rodent models and possible strength of NHP comparisons for human risk assessment.
Limitations in Rodents for investigating biological mechanisms and possible dose levels of concern for CNS space radiobiology:
• Drastically reduced numbers of neuron cells and synapses compared to humans or NHPs.
• Much higher levels of neurogenesis compared to humans or NHPs.
• Reduced axon size and number of synapses compared to humans and NHPs.
• Reduced pre-frontal cortex size and drastically reduced development of frontal lobe where higher cognition occurs (neocortex is 27% in rats, 72% in monkeys, 80% in humans).
• Performance and cognition tests limited compared to human abilities including inability to respond to visual cues.
• Manifestations of pathology of Alzheimer's disease and other late effects extremely limited (partially reconstructed in transgenic mice/rats).
• Genetic overlap of the rodent CNS with human CNS is small (20% compared to >80% in NHP).
Attributes for use of NHPs for estimating GCR risks:
• High level of genetic overlap.
• Developed neocortex, including more similar levels of neurons, synapses, and rates of neurogenesis.
• NHPs have forward-facing eyes and complex visual behavior, which is not found in rodents.
• NHPs have been shown to contain mirror neurons in the pre-frontal cortex that are specific to a particular action, and part of a brain network. Mirror neurons are not believed to exist in rodents.
• NHPs develop plaques and other pathological lesions observed in Alzheimer's or Parkinson's diseases.
• NHP share many common features related to memory and cognition with humans that are not found in rodent research models.
• NHPs can be trained for identical cognitive testing including responding to visual cues that are used in human studies making translation of results immediately analyzable.
astronauts helped bring attention to the possible effects of HZE nuclei on brain function (NAS, 1973) .
Non-human primates
Non-human primates (NHP) and humans are quite similar in their genetic, physiological, pharmacokinetic, and neurobiological characteristics while there are a large number of important differences between rodents and humans (Weatherall, 2006; Dorus et al., 2004; Heekren et al., 2008) . Non-human primates are used widely for specific areas of research including HIV/AIDS and infectious diseases, and neuroscience research (reviewed by the Weatherall Report 2006). Research on drug addiction, Parkinson's disease, Alzheimer's disease and stroke includes the use of NHP is being pursued in the U.S. and many other countries. Because of cross-species differences between humans and rodents, the determination of clinical significance for CNS health risks remains an important problem, especially if based on studies in rodents alone. This important issue is compounded for CNS cognitive risks which are known to originate in the frontal cortex, which is highly under developed in rodents compared to humans although rodents do provide some indication of cognitive risks related in the frontal cortex (Davis et al., 2014; Lonart et al., 2012) . A well-known example in inter-species differences in risk assessment is the dose for acute death for 50% of a population from low LET radiation exposure occurs at 3.5 Gy for humans and non-human primates, while is as high as 7 Gy for various species or strains of rodents. At this time it is not clear if humans would be more or less sensitive to CNS risks compared to observations in rodent models. In broad-terms, mice and rats are used to investigate biological mechanisms and possible dose levels of concern, however are limited in representing human risks due to biological differences as summarized in Table 2 . However, NHP research requires much higher costs, and extra-levels of review and expanded ethical considerations before being considered. It is important that such studies be preceded with extensive research in cell and rodent models in order to first indicate if potential CNS risks are possible. Considerations of the feasibility of deep space missions and time-lines for missions planning relative to research maturity are also needed.
In the mid-1960s, the U.S. Air Force and NASA supported experiments that studied acute and late radiation risks from X-rays and protons of irradiated Rhesus monkeys (reviewed in Dalrymple et al., 1991; Wood, 1991; Lett et al., 1991) . Several proton accelerators in the U.S., including Brookhaven National Lab, were used to study a wide spectrum of proton energies in these studies. Subgroups of the cohorts were followed to study cancer and cataract risks. The study ended in the early 1990s when the last monkeys died. The results proved to be critical in preparing for the Apollo missions because the biological effects of solar protons that where largely unknown at the time, and provided important information on the risks associated with acute effects, and late on cataract and cancer formation from radiation exposure involving solar protons (NCRP, 1989) . No studies on CNS effects were made with monkeys that were irradiated largely with high doses of X-rays or protons (>1 Gy). However balloon-borne rhesus monkeys were examined for CNS lesions after short-duration flights (Haymaker et al., 1970) .
Behavioral studies of CNS risks
As noted above a major difference between CNS effects and cancer risk assessments is the lack of a human data set such as the epidemiology studies of the atomic-bomb survivors, which could be combined with RBE factors determined experimentally to predict CNS risks in astronauts from specific space mission. A second major difference is the observation of endpoints measured in experimental models that directly reflects the risk to humans. Behavioral tests in mice and rats are a major focus of space CNS radiobiology, however the extrapolation of these results to humans has not been established. We review these studies next with a focus on the understanding dependencies on dose, particle type or LET, sex, age at exposure and time after exposure. In Table 3 we show a snapshot of these studies that illustrates the variety of tests utilized in different studies, including areas of the brain considered, the types of radiation and doses used, and whether significant differences were observed. A large number of behavior tests have been considered in mice and rats that indicate significant deficits will occur at doses of 0.5 Gy and higher of HZE particles, and potential detriments at lower doses. Only a few particle species have been used in report to date with Fe, H and Si most frequent and many fewer studies with other GCR nuclei. No studies have been made for a chronic exposure or for the mixed radiation field that occurs in space. Brain areas indicated to lead to cognitive detriments in these studies include the striatum, hippocampus, and the pre-frontal cortex.
Sensorimotor deficits and neurochemical changes were observed in rats exposed to low doses of 56 Fe (Joseph et al., 1992 (Joseph et al., , 1993 . Doses below 1 Gy reduced performance, as tested by the wire suspension test. Behavioral changes were observed as early as 3 days after radiation exposure and lasted up to 8 months. Biochemical studies showed that the K + -evoked release of dopamine was significantly reduced in the irradiated group, along with alteration of nerve signaling pathways (Joseph and Cutler, 1994) . Rabin et al. (2005) Negative result were reported by Pecaut et al. (2004) , with no behavioral deficits observed in female C57/BL6 mice in a 2 to 8 week period following exposure to 0, 0.1, 0.5 or 2 Gy accelerated iron ions (1000 MeV/u 56 Fe) using open-field, rotorod, or acoustic startle habituation tests. There is evidence that deficits in conditioned taste aversion (CTA) are induced by low doses of heavy ions Rabin et al., 1989 Rabin et al., , 1991 Rabin et al., , 2000a Rabin et al., , 2000b Rabin et al., , 2003 . The CTA test is a classical conditioning paradigm that assesses avoidance behavior that occurs when ingestion of a normally acceptable food item is associated with illness. This is considered a standard behavioral test of drug toxicity (Riley and Tuck, 1985) . The dopaminergic system was associated with radiation-induced changes in CTA, whereby amphetamine-induced CTA, which depends on the dopaminergic system, was affected by radiation, whereas lithium chloride-induced CTA, which does not involve the dopaminergic system, is not affected by radiation. It was established that the degree of CTA due to radiation was LET-dependent and that 56 Fe particles are the most effective among the various low and high LET radiation types that have been tested (Rabin et al., , 1991 . Acute doses as low as 0.2 Gy of 56 Fe ions appear to have an effect on CTA in these studies.
The relative effectiveness and threshold doses of different types of heavy particles on cognitive/behavioral performance were investigated in Sprague-Dawley rats (Rabin et al., 2007b . The relationship between radiation quality and possible thresholds was studied for the HZE particle-induced disruption of amphetamineinduced CTA learning. A similar pattern of responsiveness to the disruptive effects of exposure to either 56 Fe or 28 Si particles on both CTA learning and operant responding. Lower dose thresholds were found for 16 O of lower LET compared to heavier particles of higher LET . These results suggested that the effectiveness of different particles for neurobehavioral dysfunction is not predicted solely on the basis of the linear energy transfer of the specific particle. The threshold doses for these effects are above the annual GCR dose in free space for some but not all particle types. However, how such effects would extrapolate to humans and the potential for any CNS repair in a chronic exposure are not understood to make any conclusions on thresholds for long-term space missions. Operant conditioning utilizes several consequences to modify a voluntary behavior. Studies by Rabin and colleagues have examined the ability of rats to perform an operant order to obtain food reinforcement using an ascending fixed-ratio schedule (FR). They found that 56 Fe doses above 2 Gy affect the appropriate responses to increasing work requirements. For tests 13 and 18 months after irradiation, Rabin et al. (2003) did not observe differences in performance between the irradiated rats maintained on control, strawberry or blueberry diets, suggesting the beneficial effects of antioxidant diets may be age dependent. Studies on rats were performed using the Morris water maze test 1 month after whole-body irradiation with 1.5 Gy of 56 Fe (1000 MeV/u) particles. Irradiated rats demonstrated cognitive impairment compared to the controls that were similar to those seen in aged rats. This leads to the possibility that an increase in the amount of ROS may be responsible for the induction of both radiation-and age-related cognitive deficits (Shukitt-Hale et al., 2000 . Denisova et al. (2002) exposed rats to 1.5 Gy of 56 Fe particles (1000 MeV/u) and tested their spatial memory in an eight-arm radial maze. Cognitive behavior deficits were observed, including exposed rats committing more errors than control rats in the radial maze and they were unable to adopt a spatial strategy to solve the maze (Denisova et al., 2002) . Studies were made to identify specific brain-region alterations in relationship to sensitivity to oxidative stress, inflammation or neuronal plasticity. The striatum, hippocampus and frontal cortex from exposed rats were isolated and compared to controls. Irradiated rats were adversely affected as reflected through the levels of dichlorofluorescein, heat shock, and synaptic proteins (for example, synaptobrevin and synaptophysin). Changes in these factors consequently altered cellular signaling (for example, calcium-dependent protein kinase C and protein kinase A), with significant correlations found with working memory errors in the radial maze. The results show differential brain-region-specific sensitivity induced by 56 Fe irradiation (Fig. 2) .
Radiation significantly attenuated the expression of hippocampal calcium-dependent PRKCs, however striatal and cortical calciumdependent PRKC expression was not affected. Raber's lab (Haley et al., 2013 ) studied the effects of 56 Fe irradiation on hippocampal function starting two weeks after wholebody irradiation. Compared to sham irradiation, radiation impaired novel object recognition and spatial memory retention in female and male C57BL/6J wild-type mice. There were no effects of irradiation on contextual fear conditioning or spatial memory retention in the water maze. These results are of major importance because they demonstrate detriments at an early time point for doses as low as 0.1 Gy. Since oxidative damage could contribute to radiation-induced cognitive changes, hippocampal and cortical levels of 3-nitrotyrosine (3NT) and lipid peroxidation, measures of oxidative damage were assessed. There were no effects of irradiation on these measures of oxidative damage. As 56 Fe irradiation can increase reactive oxygen species (ROS) levels, which may contribute to the impairments in novel object recognition, the effects of the antioxidant alpha-lipoic acid (ALA) on cognition following sham irradiation and irradiation were also assessed. ALA did not prevent radiation induced impairments in novel object recognition and impaired spatial memory retention of sham-irradiated and irradiated mice in the probe trial after the first day of hidden platform training in the water maze. Other studies by Raber et al. have found significant changes in contextual fear conditioning and spatial memory retention at later time points (3 months or longer). It is interesting to compare these differences at early and late time-points in relation to the kinetics of neurogenesis in the dentate gyrus where neuron integration occurs over several weeks. This suggests that damage to neural stem cells and supporting cells in the micro-environment may not manifest deficits for more than 1 month post-IR, especially at lower doses (<1 Gy). The studies of Britten Lonart et al., 2012) has considered the possibility that neurocognitive tasks regulated by the prefrontal cortex could be impaired after exposure to low doses of HZE-particles, which could prevent astronauts from performing complex executive functions. They used male Wistar rats that received either sham treatment or irradiated and tested 3 months later for their ability to perform attentional set shifting. Compared to the controls, rats that received 0.2 Gy of 56 Fe
(1000 MeV/u) particles showed significant impairments in their ability to complete the attentional set-shifting test, with only 17% of irradiated rats completing all stages as opposed to 78% of the control rats. The majority of failures (60%) occurred at the first reversal stage, and half of the remaining animals failed at the extra-dimensional shift phase of the studies. These observations suggest that exposure to mission relevant doses of 56 Fe particles results in the loss of functionality in the pre-frontal cortex, however further investigation is needed to identify other brain regions, including the anterior and posterior cingulated cortex and basal forebrain that are possibly impacted by space radiation exposure.
Further studies with other HZE particles at doses below 0.1 Gy, and chronic or fractionated doses up to cumulative doses of 0.1 to 0.2 Gy are suggested as a continuation of these studies.
Biomarker and mechanistic studies of CNS risks
An extensive number of biomarker and mechanistic studies have been reported using cell culture or rodent models. Experiments have considered various types of neurons, neuronal stem cells (Fike et al., 2009) , microglial cells and astrocytes. Indicators of damage include reactive oxygen or nitric-oxide species, and various studies on signaling molecules. Several studies have focused on alterations in neurogenesis and neuroinflammation. More recent studies have used transgenic mice to study AD pathology and related AD biomarkers including amyloid-beta (Aβ), tau-protein, changes in long-term potentiation (LTP) and alterations in dendritic morphology. Other studies have considered serum biomarkers , gene arrays (Lowe and Wyrobek, 2012; Shukitt-Hale et al., 2013) and micro-RNA (Shi et al., 2012) . The brain (micro)vasculature which exhibits a comparable vulnerability for radiation damage to that found elsewhere in the body (Reinhold and Hopewell, 1980) has also been studied (Mao et al., 2010) . Radiation-induced damage to oligodendrocytes and endothelial cells of the vasculature accounts for major aspects of the pathogenesis of brain damage that can occur after high doses of low-LET radiation (Schultheiss et al., 1995) and should be considered for high LET radiation (NCRP, 2006) .
Cell loss, apoptosis and autophagy
An early theme in CNS space radiobiology was experiments considering neuronal cell loss after HZE particle exposure (NAS, 1973; Philpott et al., 1985) . Two to three weeks following doses of 0.1, 1 and 10 Gy of 400 MeV/u 20 Ne particles slowed to an energy of 40 MeV/u with an absorber, the percentage of necrotic cells in the cerebrum of pocket mice was <0.0005, 0.003, and 0.04%, and smaller number in other brain areas studied (Kraft et al., 1979) . Slightly larger changes but insignificant losses were observed in the cerebrum and dentate gyrus within 1 day of exposure. Studies by Lett (1994, 1996) considered photoreceptor cell loss through what was likely apoptosis at different time points in New Zealand White rabbits following doses of 0.5 to 3.5 Gy of 56 Fe (600 MeV/u). Photo-receptor losses approaching 10% were observed by 20 month post-exposure to 2.88 Gy of 56 Fe. Similar losses were not observed at long post-exposure times using γ -rays, Ne or Ar particle beams. Extrapolation of these results to space relevant doses of HZE particles (0.1 Gy or less) suggests immediate or delayed loss of neurons should not play a significant role for spaceflight. In a series of studies over many years, Rabin and co-workers have shown that even though exposure to HZE particles occurs at low fluence rates, HZE exposure result in molecular changes similar to those seen in aged animals (Rabin et al., , 2007a (Rabin et al., , 2012 in the hippocampus as measured by accumulation of ubiquitin inclusion bodies such as P62/SQSTM1, autophagosome marker microtubule-associated protein 1 beta light chain 3 (MAP1B-LC3), beclin1 and proteins such as mammalian target of rapamycin (mTOR). For both short (36 h) and long (75 days) intervals exposure, molecular markers indicated that the loss of autophagy function occurred shortly after exposure but was recovered via inhibition of mTOR. Poulose et al. (2011) also looked at correlations in levels of protein kinase C alpha (PKC-a), a key G protein modulator involved in neuronal survival and functions of neuronal trophic factors, nuclear factor kappa B (NF-κ b) and glial fibrillary acidic protein (GFAP), indicating glial cell activation 75 days after exposure. Overall their findings detail the molecular effects of 16 Oparticle radiation as they relate to early and late oxidative stress, inflammation and loss of autophagy in rat brains.
Altered neurogenesis
In recent years, studies with stem cells uncovered that neurogenesis still occurs in the adult dentate gyrus subventricular zone (SVZ) and the subgranular zone (SGZ). Specific hippocampaldependent cognitive impairment such as memory and learning are being considered in terms of changes to neurogenesis (Squire, 1992; Eisch, 2002; Rola et al., 2004; Raber et al., 2004) . Studies of neurogenesis have provided an approach to understand mechanistically some of the factors that affect hippocampal risk from space radiation exposure. Accumulating data indicates that radiation not only affects differentiated neural cells but also proliferation and differentiation of neuronal precursor cells, and even adult stem cells. Recent evidence points out that neuronal progenitor cells are sensitive to radiation (Mizumatsu et al., 2003; Monje et al., 2002; Tofilon and Fike, 2000) . Acharya et al. (2011) showed that human neural stem cell transplantation ameliorates radiation-induced cognitive dysfunction in mice following radiation exposure. Studies on low-LET radiation showed that high dose radiation stops not only the generation of neuronal progenitor cells, but also their differentiation into neurons and other neural cells. Cells in the dentate SGZ undergo dose-dependent apoptosis above 2 Gy of X-ray irradiation. The production of new neurons in young adult male mice is significantly reduced by relatively doses of 2 Gy or more of X-rays. Measurements of activated microglia indicated that changes in neurogenesis were associated with a significant dose-dependent inflammatory response even 2 months after irradiation. This work suggests that the pathogenesis of radiation-induced cognitive injury may involve loss of neural precursor cells from the SGZ of the hippocampal dentate gyrus and alterations in neurogenesis.
Studies of altered neurogenesis in the SGZ after radiation exposure using HZE nuclei were considered in rats by Casadesus et al. (2004 Casadesus et al. ( , 2005 and in mice by Rola et al. (2004 Rola et al. ( , 2005 Rola et al. ( , 2008 and more recently by Riviera et al. (2014) . Casadesus et al. (2005) demonstrated that HZE radiation led to progressive loss of neuronal progenitor cells in the SGZ at doses of 1 to 3 Gy of 56 Fe (1000 MeV/u) in a dose-dependent manner. These results indicate that high-LET radiation has a significant and long-lasting effect on the neurogenic population in the rat hippocampus that involves cell loss and changes in the microenvironment. Rola et al. (2008) quantified neurogenesis and activated microglial as an indicator or neurogenesis at two months post-IR using doses of 0.5-4.0 Gy of 56 Fe (1000 MeV/u). Significant changes were not observed at 0.5 Gy, which is potentially an important result for understanding GCR risks to the CNS because HZE particle mission doses are not expected to exceed 0.1 Gy. However it will be important to extend these studies to longer post-irradiation times and for lower particle doses with adequate sample sizes. Riviera et al. (2014) compared acute exposures of 1 Gy to 5 × 0.2 Gy fractions of 56 
Fe
(1000 MeV/u) in 1-day intervals using transgenic mice which were inducible to allow cell tracking. They found few significant differences between acute and fractionate exposures. These studies are at dose-rates much higher than in deep space (∼0.5 mGy/d at solar minimum), however are the first to consider fractionation to study CNS effects with HZE particles.
Neuroinflammation
Neuroinflammation has been recognized as a major factor associated with neurodegenerative diseases, such as AD and Parkinson's disease (PD) (Glass et al., 2010) . Neuroinflammation is a fundamental reaction to brain injury, characterized by activation of resident microglia and astrocytes and local expression of a wide range of inflammatory mediators. ROS are key signaling molecules in the inflammatory response and therefore considered as a key contributor in neurodegenerative diseases. Increasing production of ROS, such as post IR exposure, can regulate the expression of diverse inflammatory mediators during brain injury, resulting in the damage or death of parenchymal cells in the brain. The fact that moderate or high doses of high LET particles produce significantly higher level of ROS compared to similar doses of low LET radiation denotes the potential initiation and amplification effects of space radiation on neuroinflammation and neurodegenerative diseases, however effects at space relevant doses have not been observed.
Studies that followed whole-brain radiotherapy in children demonstrated a late side effect of radiation somnolence syndrome (RSS), in which an inflammatory response has been considered as a key player (Ballesteros-Zebadúa et al., 2012). Proinflammatory cytokines such as interleukin-1β, tumor necrosis factor-α, interleukin-6 and interleukin-18 were found in the brain post low LET radiation. COX-2 pathways are implicated in neuroinflammatory processes caused by low-LET radiation. COX-2 up regulation in irradiated microglia cells leads to prostaglandin E2 production, which appears to be responsible for radiation induced gliosis (over proliferation of astrocytes in damaged areas of CNS) (Kyrkanides et al., 2002; Moore et al., 2005; Hwang et al., 2006) . Other inflammatory markers such as GFAP, intercellular adhesion molecule-1 and NF-κ b are also found involved in the brain response to radiation (Ballesteros-Zebadúa et al., 2012) .
Human data on HZE particles radiation are lacking, but acute and chronic neuroinflammation has been studied in the mouse brain following exposure to HZE particles. The estimated RBE value of HZE irradiation is 3 compared to gamma irradiation, for induction of an acute neuroinflammatory response . Increased expression of the CCR2 receptor in the subgranular zone 9 months after 1-3 Gy 12 C or 56 Fe irradiation .
However, studies published to date (Rola et al., 2008; Cherry et al., 2012) do not indicate a significant induction of neuroinflammation at lower HZE particle doses (0.1 to 0.5 Gy). It will be important to extend these studies to other particle types, chronic exposures of several weeks, and for space mission relevant organ doses from 0.05 to 0.2 Gy.
Oxidative and radical damage
Oxidative damage is one of the main inducers of CNS detriments. In vitro and in vivo experiments have been performed both showing ROS at higher doses, while in vitro experiments have reported direct observation of ROS at low acute HZE doses (<0.5 Gy). Adult rat neural precursor cells from the hippocampus show an acute dose-dependent apoptotic response that was accompanied by an increase in ROS (Limoli et al., , 2007 . Giedzinski et al. (2005) reported that relative ROS levels were increased for doses of 1 to 10 Gy of Bragg-peak 250 MeV protons at post-irradiation times (6 to 24 hours) compared to unirradiated controls. The increase in ROS after proton irradiation was more rapid than that observed with X-rays and showed a significant dose response at 6 and 24 hours, increasing about 10-fold at a rate of 3% per Gy. At 48 hours post irradiation, ROS levels fell below controls and coincided with minor reductions in mitochondrial content. Use of the antioxidant alpha-lipoic acid (ALA) (before or after irradiation) was shown to eliminate the radiation-induced rise in ROS levels. High LET radiation led to significantly higher levels of oxidative stress in hippocampal precursor cells when compared to low LET (X-rays or protons). The use of ALA was able to reduce ROS levels below background levels when added before or after 56 Fe particle irradiation.
Using the DCF-associative fluorescence measure of oxidative stress, Denisova et al. (2002) considered possible increases in oxidative stress in the striatum, hippocampus and frontal cortex of 2 month old Sprague-Dawley rats at 5 weeks post irradiation of 1.5 Gy of 56 Fe (1000 MeV/u). For this time-point and dose, only the frontal cortex showed an increase in oxidative stress. However, there was no correlation of DCF levels in frontal cortex with tests of reference memory in the same animals. Suman et al. (2013) used flow cytometry to compare increases in ROS in the cerebral cortex of C57BL/6J female mice from 1.6 Gy of 56 Fe (1000 MeV/u) to 2.0 Gy of gamma-rays at 2 and 12 months post-IR. A significant increase was observed for both time points for 56 Fe exposures but not for gamma-rays. However, no studies were performed at space relevant HZE particle doses (0.1 Gy or less) or for chronic exposures. Several mechanistic studies of CNS injury have led to important insights into radiation effects. Because of the HZE induced ROS observed in prior studies, Villasana et al. (2013b Villasana et al. ( , 2013a investigated the effects of the ALA on cognition following sham-irradiation and irradiation with 56 Fe (600 MeV/u). In this study male mice were irradiated (brain only) for doses of 3 Gy or sham-irradiated at 6-9 months of age. Half of the mice were fed a regular chow and the other half of the mice were fed a caloric-matched diet containing ALA starting two-weeks prior to irradiation and throughout cognitive testing. Levels of 3-nitrotyrosine (3NT), a marker of oxidative protein stress, and levels of microtubule-associated protein (MAP-2), a dendritic protein important for cognition, were assessed using immunohistochemistry and confocal microscopy. In shamirradiated mice, ALA treatment impaired cortical-dependent novel object recognition and amygdala-dependent cued fear conditioning. Interestingly ALA prevented radiation-induced impairments in spatial memory retention in the hippocampal and cortical dependent water maze probe trials following reversal learning. In the hippocampal dentate gyrus of mice on regular diet, irradiated mice had higher levels of MAP-2 immunoreactivity than sham-irradiated mice. Villasana et al. (2013b) concluded that ALA might have differential effects on the brain under normal physiological conditions and those involving environmental challenges such as cranial irradiation. However, these studies will need to be extended tolower doses (<0.1 Gy) since the importance of ROS and anti-oxidants may be differential at high and low doses. Some but not all animal experimental studies suggest antioxidant and anti-inflammation should be investigated as countermeasures for CNS risks from space radiation. Diets of blueberries and strawberries were shown to reduce CNS risks after heavy ion exposure. Estimating the effects of diet and nutritional supplementation would be a primary goal of CNS research on countermeasures. On the other hand the recent study from the Raber lab (Haley et al., 2013) showed no protective effect from anti-oxidants in reducing early cognitive changes following doses of 0.1 to 1 Gy of Fe particles. These results suggest that high LET radiation especially at low to moderate doses is less dependent on early oxidative stress responses to cause illicit detrimental effects. Some recent experiments suggest, at least for acute high-dose irradiation, that an efficient radioprotection by dietary supplements can be achieved, even in case of exposure to high-LET radiation. Melatonin which has anti-oxidant properties was found to be protective in preventing inhibition of neurogenesis (Manda et al., 2008a (Manda et al., , 2008b following high dose 56 Fe (500 MeV/u) exposures of mice. There is additional evidence that dietary antioxidants (especially strawberries) can protect the CNS from the deleterious effects of high doses of HZE particles (Rabin et al., , 2009 ). However, because the mechanisms of biological effects are likely different at low dose-rates compared to acute irradiation, new studies for protracted exposures would be needed to understand the potential benefits of biological countermeasures. Concerns about the potential detrimental effects of antioxidants were raised by a meta-study of the effects of antioxidant supplements in the diet of normal subjects (Bjelakovic et al., 2007 , see also Durante and Cucinotta, 2008) . Bjelakovic et al. (2007) did not find statistically significant evidence that antioxidant supplements have beneficial effects on mortality. On the contrary, they concluded that β-carotene, vitamin A, and vitamin E seem to increase the risk of death. Concerns include that antioxidants may allow rescue of cells that still sustain DNA mutations or altered genomic methylation patterns following radiation damage to DNA, which can result in genomic instability. Other concerns may occur for neurocognitive effects were a delicate balance of redox states is crucial.
Long-term potentiation (LTP)
Synaptic plasticity is the ability of a chemical synapses to change their strength. Long-term potentiation (LTP) refers to a long-lasting enhancement in signal transmission between two neurons that results from stimulating them synchronously. It is one of several phenomena underlying synaptic plasticity. Memories are thought to be encoded by modification of synaptic strength. Measurements of LTP are used as a cellular model for information storage in the brain. Vlkolinský et al. (2007) exposed C57BL/6J mice to 56 Fe (600 MeV/u) particles at doses of 0, 1, 2, and 4 Gy (brain only) and measured LTP one-month post-IR, including studies with the additional challenge of the peripheral immunological stressor, lipopolysaccharide (LPS) injected 4 h before hippocampal brain slices were prepared. LTP was not changed at 1 Gy and reduced at 2 Gy compared to controls without LPS injection. LTP was reduced at 0 and 1 Gy with the addition of LPS but was increased at 2 Gy. Additional studies Vlkolinský et al. (2008) were performed at later times (up to 12 months post-IR) and indicated that 2 Gy doses of 56 Fe modified the hippocampal response to an immunological stressor, however only transient differences were seen at the dose of 1 Gy. In a more recent study, Rudobeck et al. (2014) used 28 Si (600 MeV/u) at acute doses of 0.25 and 1.0 Gy to test for changes in synaptic plasticity in hippocampal slices prepared from ventral hippocampus in male C57BL/6J mice. Significant changes were observed at 1 Gy but not at 0.25 Gy. However, in study by Raber et al. (2014) also using 28 Si (600 MeV/u) at doses of 0.25 and 1 Gy results were dependent on whether mice were naïve or previously exposed to cognitive testing. Here there was a significant LTP enhancement at 0.25 and 1.0 Gy in naïve mice, while mice that were previously exposed to a contextual freezing test and exposed to 0.25 Gy showed a further LTP enhancement compared to naïve mice exposed to 0.25 Gy, but not at 1.0 Gy. Raber et al. (2014) note that astronauts will undergo psychological and physical stressors during spaceflight, which suggest the use of mice exposed to cognitive tests could better represent spaceflight conditions. These experiments for 28 Si and 56 Fe suggest that there are complicated relationships between dose, particle type and individual differences related to psychological stressors and adaptation that could impact changes in LTP, and therefore will require further investigation, especially at lower doses (0.01 to 0.2 Gy).
Modifications to dendritic morphology
Neuron cells contain a soma, which includes the cell nucleus, axon, and a dendritic tree, which includes thousands of dendritic spines. An axon arises from the soma at a site called the axon hillock and extends for a long distance, which can be as far as 1 meter in humans. Dendrites are thin structures, also arisen from the soma, which can extend for hundreds of micrometres, while branching multiple times giving rise to a complex "dendritic tree". Dendritic spines are the postsynaptic elements of synapses found on dendrite branches in neuronal cells of the mammalian brain.
Recently Parihar and Limoli (2013) and Parihar et al. (2014) examined changes in dendritic morphology and plasticity in hippocampal slices from mice following doses of 0.1 and 1 Gy of protons or 1 and 10 Gy or X-rays at 10 and 30 day post-irradiation. Significant changes in the number of dendritic branches, branch points, and dendritic length were observed at 30 d post-IR indicating reduction in dendritic complexity has occurred due to radiation damage. Dendritic spines can be classified as filopodia (emerging spines) or spines of varying sizes or shapes including immature long spines, and mature stubby and mushroom spines. Significant decreases were observed in the number of filopodia and long spines for proton exposures of 0.1 and 1 Gy, but not in mushroom and stubby spines. These differences are consistent with the larger sizes of filopodia and long spines, which are intersected by a larger number of radiation tracks, however a relationship to changes in neuron plasticity is more likely. Using older experimental methodologies, Brizee et al. (1980) observed changes in dendritic morphology following prenatal irradiation of squirrel monkeys with 2 Gy of X-rays, which suggests these newer results (Parihar et al., 2014) with more sophisticated imaging approaches would also reflect the changes to be observed in human neuronal cells exposed to space radiation. New results for HZE particles using the experimental methodologies are expected to be reported in the near future by Limoli's lab.
Estimates of HZE particle traversals to the CNS have been made for neuronal soma using the LET approximation by Gauger et al. (1986) and Curtis et al. (1998) , and with the additional contribution from delta-rays by Cucinotta et al. (1998) , however these predictions greatly under-estimate the number of GCR particles traversals to axons or dendritic trees, or the effects of particle traversals on the neuron micro-environment. Estimates of fluence rates in tissues for different particle types are useful descriptive parameters of the physical environment and possible damage to the CNS. Table 4 using the NSCR-2012 model (Cucinotta et al., 2013a) shows that number of particle hits per year for GCR particles of increasing ionization power in different regions of the hippocampus under typical spacecraft shielding. Clearly a large number of hits from HZE particles to sensitive brain regions will occur behind typical shielding amounts.
Cross-sectional areas of soma are typically up to a few 100 μm 2 , which compares to cross-sectional areas of spines and the dendritic trees of neuron cells of approximately 10 and 4000 to more than 20,000 μm 2 , respectively. Similarly the cross sectional area of axons from individual neurons can be very large compared to the soma, and varies over several orders of magnitude due to their variable lengths (up to 1 m) and diameters (up to 20 microns).
Calculations by Alp, Limoli, and Cucinotta (in preparation, 2014) shown in Fig. 4 describe in detail the unique patterns of energy depositions that occur within mouse granule neurons as simulated using the Neuromorph data-base (Parekh and Ascoli, 2013) and a Monte Carlo model or HZE particle tracks (Plante and Cucinotta, 2008) . HZE particles produce large energy deposition (>200 eV) in small volumes (<20 nm) of biomolecular scale that are not possible with low LET radiation for doses below a few 10's of Gy (Cucinotta et al., 2000) . Clearly, qualitative differences in energy deposition for different radiation qualities occur and will likely result in radiation quality dependent damage to synapses.
Acceleration of Alzheimer disease pathologies
Alzheimer's disease leads to massive neuronal cell and synapse loss beginning in the enthorhinal cortex and hippocampus. Amyloid-beta (Aβ) plaques, neurofibrillary tangles (NFTs) which contain the hyper-phosphorylated form of the tau protein, and changes to dendritic morphology related to synapse loss are important biomarkers of AD (Gotz and Ittner, 2008) . Mutations in the amyloid precursor protein (APP), presenilin 1 (PSEN1) and presenilin 2 (PSEN2), which are components of the proteolytic γ -secretase complex that along with β-secretase form the Aβ complex, are common in familial cases of AD. Wild type mice express significant levels of APP however human mutations leading to high levels of Aβ production are not observed. Other differences between mice and humans for genes important in AD occur, with the result that mice do not usually show AD related pathologies. Transgenic mice expressing APP, PSEN1, PSEN2 and other AD related genes have been produced, which mimic the cognitive changes associated with AD and AD related pathologies (Gotz and Ittner, 2008) . Space radiobiology researchers have begun to use several different AD transgenic mouse models to study if HZE particle exposure leads to an early time course for cognitive detriments and AD related pathologies. Vlkolinsky et al. (2010) examined whether HZE particle radiation accelerated the age-related neuronal dysfunction using transgenic mice overexpressing human amyloid precursor protein (APP). APP23 transgenic mice exhibit age-related behavioral abnormalities and deficits in synaptic transmission. 7-week-old male APP23 transgenic mice were exposed to brain-only 56 Fe-particle radiation (600 MeV/u; 1, 2, 4 Gy) synaptic transmission in hippocampal slices were recorded at ages of 2, 6, 9, 14 and 18-24 months postirradiation, and stimulated Schaeffer collaterals and recorded field excitatory postsynaptic potentials (fEPSP) and population spikes (PS) in CA1 neurons. Results showed that radiation accelerated the onset of age-related fEPSP decrements recorded at the PS threshold from 14 months of age to 9 months and reduced synaptic efficacy.
At 9 months, radiation also reduced PS amplitudes. At 6 months, they observed a temporary deficit in paired-pulse inhibition of the PS at a dose of 2 Gy. The lab of O'Banion examined the effects of 56 Fe particle irradiation in an APP/PS1 mouse model of AD (Cherry et al., 2012) . APP/PS1 mice show Alzheimer's pathologies at an old age and the goal of the study was to see if low doses of space radiation accelerated the age of appearance of AD pathologies. At 6 months after exposure to 0.1 and 1.0 Gy 56 Fe (1000 MeV/u) radiation, APP/PS1 mice show decreased cognitive abilities measured by novel object recognition testsin male mice. Results for contextual fear condition tests for male mice were changed at 1.0 Gy and not significantly different from controls at 0.1 Gy. For female mice only 1.0 Gy was used and a significant change for novel object recognition but not contextual fear conditioning was found. Male mice showed acceleration of Aβ plaque pathology (Fig. 3) . Increases were not due to higher levels of APP or increased cleavage as measured by levels of the beta C-terminal fragment of APP. Additionally, no change were observed in microglial activation levels judging by CD68 and Iba-1 immunoreactivities in and around Aβ plaques or insulin degrading enzyme, which has been shown to degrade Aβ. Immunohistochemical analysis of ICAM-1 showed evidence of endothelial activation after 1 Gy irradiation in male mice, suggesting possible alterations in Aβ trafficking through the blood brain barrier as a possible cause of plaque increase.
Signaling and neuro-transmitter changes
The electrical and chemical signaling processes in the CNS, which are related to a variety of functions and processes present distinct modes for perturbations by radiation to occur. An early CNS space radiobiology studies (Hunt et al., 1990) showed deficits in 3-methooxytyramine (3-MT), a metabolite that reflects dopamine releases in rats, occurred at 3 d and 6 m post-IR for high doses of 56 Fe (600 MeV/u). This study was followed by more extensive biochemical studies of changes to dopameric neurons by Joseph et al. (1992 Joseph et al. ( , 1993 Joseph et al. ( , 1999 and Villalobos-Molina et al. (1994) using doses of 0.1 to 1 Gy of 56 Fe. Oxotremorine K+-evoked release of dopamine from perifused striatal slices was found to be degraded from 3 d to 6 m post IR for doses as low as 0.1 Gy, and shown to be related to a loss of sensitivity of muscarinic receptors. In contrast to the studies of Joseph et al., the laboratory of Gatley used microPET imaging (Rice et al., 2006 (Rice et al., , 2009 and staining of rat brain sections for tyrosine hydroxylase and found no changes in the midbrain dopamine system following doses of 1.2 and 2.4 Gy of 56 Fe (1000 MeV/u). More recently Davis et al. (2014) used adult male Long-Evans rats exposed to doses of 0.25 to 2 Gy of 150 MeV protons, and found a correlation between deficits in dopamine transporters and responses to attentional deficit tests in individual rats. Studies of glutamate transport in co-cultures of human neurons and astrocytes cells were performed by Sanchez et al. (2009 Sanchez et al. ( , 2010 using doses from 0.1 to 2 Gy of protons (250 MeV), 12 C (290 MeV/u) or 56 Fe (1000 MeV/u). Glutamate uptakes occurs through the astrocytic transporter. These studies show an expected reciprocal response in glutamate transport of neurons and astrocytes with increased uptake in neurons post-IR and decreases in astrocytes. In vivo studies using Wistar rats exposed to 0.6 Gy of 56 Fe (1000 MeV/u) showed significant reductions in the NR1, NR2A, and NR2B subunits of the glutameric NMDA receptor at 90 d post-IR (Machida et al., 2010) , however the authors suggested further studies would be needed to determine the impacts of these reductions on neurocognitive impairment found in the same animals.
Fike and co-workers have assessed the molecular distribution of the behaviorally induced immediate-early gene Arc (activity reg- ulated cytoskeleton-associated protein) (Rosi et al., , 2012 , which plays an important role in neuroplasticity and memory. An important hypothesis is that alterations to the dentate gyrus observed after HZE particle exposure is related to expression levels of Arc . Using doses of 0.5 Gy and 1.0 Gy of 56 Fe (600 MeV/u), Raber et al. (2013) showed that there was a significant correlation between deficits in tests for contextual freezing and the percentage of Arc-positive cells in the enclosed and freeblade of the dentate gyrus 3-months post-IR, and suggested that the enclosed blade is more important for contextual freezing and the free blade for cued freezing.
Individual risk factors
Individual factors for CNS risks of potential importance are age, sex, genetic factors, prior radiation exposure, and previous head injury such as concussion. The recent study noted above by Raber et al. (2014) suggests adaptation to psychological and physical stressors in space may also lead to individual differences in early CNS responses. Carey et al. (2007) and Rabin et al. (2012) considered the effects of age using male Fischer-344 rats exposed to 0.25 to 2 Gy of 56 Fe (1000 MeV/u) at ages of 2, 7, 12 and 16 months and tested for DA levels, and spatial learning and memory tasks. The model of Casarett (Rubin and Casarett, 1968; Cox et al., 1983) would predict that latency would be reduced at older ages compared to younger ages of exposure, which is supported by these studies. However, including the dependence of the time of performance testing suggests a more complicated relationship may occur. Rabin et al. (2012) note that older animals show increased detriments compared to younger animals for plus-maze performance (Rabin et al., 2007a) and amphetamine-induced taste aversion learning (Carrihill-Knoll et al., 2005) , however these tests can only be measured at a single time point. Rabin et al. (2012) studies of disruption of operant-responding, which allows for multiple testing at different times points of individual animals, suggests a complicated relationship between age at irradiation and age of testing occurs that requires further investigation.
The Apolipoprotein E (APOE) has been shown to be an important and common factor in CNS responses that leads to differences between males and females. APOE controls the redistribution of lipids amongst cells and is expressed at high levels in the brain (Raber et al., 1998; Laskowitz and Vitek, 2007) . For females, apoE4 increases the risks of AD compared to apoE4, while apoE2 decreases AD risk. Studies have considered the effects of space radiation for the major isoforms of apoE, which are encoded by distinct alleles (ε2, ε3, and ε4). The isoform apoE4 has been shown to increase the risk of cognitive impairments, and to lower the age for Alzheimer's disease. It is not known if the interaction of radiation sensitivity or other individual risks factors is the same for high and low LET radiation. Other isoforms of apoE confer higher risk for other diseases. People who carry at least one copy of the APOE ε4 allele are at increased risk for atherosclerosis, which is also suspected to be a risk increased by radiation. People who carry two copies of the APOE ε2 allele are at risk for a condition known as hyper-lipoproteinemia type III. It will be extremely challenging to consider genetic factors in a multiple radiation risk paradigm. For female mice significant effects of irradiation on exploratory activity or measures of anxiety for different apoE isoforms were not found (Villasana et al., 2013a) . Villasana et al. (2006 Villasana et al. ( , 2008 Villasana et al. ( , 2010 Villasana et al. ( , 2011 Villasana et al. ( , 2013a have shown increased neurocognitive deficits in female apoE4 mice following 56 Fe exposure, and a dependence on apoE isoforms was shown in cognitive tests in mice two weeks post-IR with 56 Fe at a dose of 0.5 Gy (Haley et al., 2012) . For male mice of different apoE isoforms more modest effects on responses to 56 Fe exposures were found (Villasana et al., 2006) . Differences between male and female mice were also observed in the studies of Cherry et al. (2012) using the APP/PS1 mouse model of AD. A recent study (Davis et al., 2014) used head only irradiation with doses of 0.25, 0.5, 1 and 2 Gy of 150 MeV protons of LongEvans rats of 10-12 weeks of age that were tested at 250 days post-IR for performance detriments using an analog of the human psychomotor vigilance test (PVT). Overall performance detriments were minimal, however in a subgroup of rats performance detriments were observed for all doses that were correlated with deficits in the levels of the dopamine transporter and to a lesser extent the D2 receptor (Davis et al., 2014) . These studies point to individual variations in CNS responses to radiation and elucidating individual differences will be important to be pursued in future research studies.
Synergistic risks in spaceflight
Space travel confers several other challenges to the CNS besides radiation exposure. These include microgravity, altered circadian rhythm that can lead to sleep deprivation, and challenges related to isolation and confinement, as well as individual responses to psycho-social interactions (Benke et al., 1993; Dijk et al., 2001; Gundel et al., 1997) . Each of these challenges present new possibilities for synergistic interactions leading to changes to cognition, including learning and memory that are being investigated due to space radiation exposures. Important areas of investigation are the role of cumulative radiation exposures where detrimental effect may only occur above a dose threshold, and how such thresholds might be modified by synergistic factors. The use of pharmaceuticals for sleep deprivation or other reasons could lead to short-term modifications of neurogenesis (Eisch, 2002) , dopamine regulation or other neuronal pathways that are also impacted by space radiation. Also combined CNS challenges may lead to distinct assessments of individual sensitivity and the effectiveness of a countermeasure.
Conclusions
At this time, reliable projections for CNS risks from space radiation exposure cannot be made due to a paucity of data for particles types, doses and dose-rates, and lack of understanding on the extrapolation of experimental results with rodents to humans. The existing animal and cellular data suggest that space radiation can produce neurological and behavioral effects, and therefore the possibility exists for impacts for a Mars mission or other long duration deep space missions. However possible dose thresholds for these effects, and the significance of these results on the morbidity to astronauts has not been elucidated. It is to be noted that the studies to date have been carried out with relatively small numbers of animals (typically <10 per dose group), and therefore testing of dose threshold effects at lower doses (HZE particle doses of <0.1 Gy/y and total GCR doses of <0.2 Gy/y) that would occur on space missions has not been carried out to a sufficient extent at this time and will require much large group sizes. Furthermore, studies with relatively few GCR species and at energies above 1000 MeV/u have not been made, nor studies with mixed fields of protons, neutrons, and HZE particles. The role of dose protraction has not been studied to any significant detail. The NASA Space Radiation Lab (NSRL) is limited to energies of 1000 MeV/u and lower, while 50% or more of the GCR HZE particle fluence in tissue is for particles with energies above 1500 MeV/u, which would be predicted to be less effective compared to lower energy particles (<1000 MeV/u) of similar LET (Cucinotta et al., 2013a) .
The majority of CNS studies have been carried out at doses of 0.5 Gy or more, while many of these studies suggest a lack of significant effects. However the studies of Rabin et al. (2011) looking at threshold doses for cognitive deficits in mice, Britten et al. (2012) considering changes to executive function, Haley et al. (2013) on early cognitive changes, Limoli's lab investigating changes to dendritic morphology (Parihar et al., 2014) , and by Cherry et al. (2012) considering AD related pathologies, indicate significant effects for acute HZE particle or proton doses as low as 0.1 Gy could occur. Certainly studies with a variety of HZE particles, simulating chronic radiation conditions, and for longer follow-up times are vitally needed in addition to the results reported to date.
Because of the uncertainty in extrapolating dose thresholds from rodents to humans, we estimate that if a dose threshold twotimes higher than the expected HZE particle dose for a Mars mission near solar minimum were established it would ensure safety of crew for a Mars mission with additional considerations of the effects of low LET GCR and SPE exposures. However current data is uncertain as to a threshold dose for clinically significant CNS effects, with estimates as high as 0.5 Gy to as low as 0.1 Gy of HZE particles possible. Reducing the uncertainty in this assumption through space radiobiology research would likely lead to a significant costs savings for space missions due to the possible mission impacts of an acute CNS risk limit with large uncertainty. A dose threshold of 0.2 Gy of HZE particles or higher would ensure that no significant in-mission CNS effects to Mars mission's crews would occur. Shielding would be an efficient countermeasure to higher doses from SPEs. Additional considerations are needed to limit possible late effects, which should be included in life-time REID limits (Cucinotta et al., 2013a (Cucinotta et al., , 2013b Cucinotta, 2014) .
In considering a long term research strategy to quantitatively assess CNS risk from space radiation exposure, the following steps are recommended: 1) Establish the most important pathological processes and behavioral tests relevant to human risk using acute low dose radiation in rodents (0.01 to 0.5 Gy) with a few representative GCR species ( 56 Fe, 28 Si, 16 O and protons).
2) Extend these studies to other particle energies and beams ( 4 He, 20 Ne, 48 Ti, etc.) to establish the radiation quality dependence of these processes. 3) Test the impact of chronic or meaningful fractionated exposures as compared to single dose exposure for different particle types including mixed radiation fields of protons and HZE particles, doses, and time points. Biological time scales important in brain function should be considered in designing the duration of chronic exposures to be used. 4) If significant effects are observed after 3), determine whether robust effects demonstrated in rodents are seen in the NHP. 5) For possible in-mission CNS risks, experiments simulating synergistic effects of space radiation and altered circadian rhythm and other spaceflight factors that might influence exposure thresholds for such effects should be considered. 6) Research on biological countermeasures to CNS risks should be pursued if 4) and/or 5) are conclusive on a risk at space relevant doses.
Finally there are many areas of neuroscience related to adverse health effects that have not been explored with HZE particle irradiation including effects on axons, the role of DNA damage and cell cycle perturbations, more extensive studies on AD risk, neuroinflammation, and autophagy, studies on protein clearance after radiation exposures, changes to dendritic morphology and synapses, and studies of other late CNS effects besides AD to a name a few. We recommend that each of these areas be considered with a significant effort to fully understand the possible risks to crews on long duration missions in deep space.
